DIKUL - logo
E-viri
  • Pathological Ventricular Re...
    Burchfield, Jana S; Xie, Min; Hill, Joseph A

    Circulation (New York, N.Y.), 2013-July-23, Letnik: 128, Številka: 4
    Journal Article

    Despite declines in heart failure morbidity and mortality with current therapies, rehospitalization rates remain distressingly high, substantially affecting individuals, society, and the economy. As a result, the need for new therapeutic advances and novel medical devices is urgent. Disease-related left ventricular remodeling is a complex process involving cardiac myocyte growth and death, vascular rarefaction, fibrosis, inflammation, and electrophysiological remodeling. Because these events are highly interrelated, targeting a single molecule or process may not be sufficient. Here, we review molecular and cellular mechanisms governing pathological ventricular remodeling.